Close
  Indian J Med Microbiol
 

Figure 2: Cases of EUS-ethanol retention therapy and percutaneous catheter drainage-ethanol retention therapy. (a) Complete regression after EUS-ethanol retention therapy for multiple hepatic cysts (left to right: computed tomography scan before therapy, at the 5-month follow-up, and at the 4.8-year follow-up). (b) Complete regression after percutaneous catheter drainage-ethanol retention therapy of multiple hepatic cysts (left to right: computed tomography scan before therapy, at the 1-month follow-up, and at the 2.8-year follow-up). (c) Partial regression in percutaneous catheter drainage-ethanol retention therapy (left to right: computed tomography scan before therapy, at the 1-year follow-up, and at the 3-year follow-up). Abdominal computed tomography scan shows the reduced cyst and re-expansion of the liver parenchyma in the right lobe

Figure 2: Cases of EUS-ethanol retention therapy and percutaneous catheter drainage-ethanol retention therapy. (a) Complete regression after EUS-ethanol retention therapy for multiple hepatic cysts (left to right: computed tomography scan before therapy, at the 5-month follow-up, and at the 4.8-year follow-up). (b) Complete regression after percutaneous catheter drainage-ethanol retention therapy of multiple hepatic cysts (left to right: computed tomography scan before therapy, at the 1-month follow-up, and at the 2.8-year follow-up). (c) Partial regression in percutaneous catheter drainage-ethanol retention therapy (left to right: computed tomography scan before therapy, at the 1-year follow-up, and at the 3-year follow-up). Abdominal computed tomography scan shows the reduced cyst and re-expansion of the liver parenchyma in the right lobe